Admission Date:  [**2146-10-19**]       Discharge Date:  [**2146-11-16**]  Date of Birth:   [**2146-10-19**]       Sex:  M  Service:  Neonatology  HISTORY:  [**Known lastname **] [**Known lastname **], boy #2 was [**Known lastname **] at 35 weeks gestation by primary cesarean section for twin gestation and concerns for growth of this twin.
Enteral feeds were begun shortly after admission to the NICU and has always been well tolerated.
Gastrointestinal status:  [**Known lastname **] was treated with phototherapy for hyperbilirubinemia of prematurity from day of life #4 to day of life #5.
Hematological status:  The infant has received no blood product transfusions during his NICU stay.
Infectious disease status:  Infant has received no antibiotics during his NICU stay.
Medications:  Iron sulfate (25 mg/mL) 0.2 cc p.o.
The infant received his first hepatitis B vaccine on [**2146-10-25**].
Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1) [**Month (only) **] at less than 32 weeks, 2) [**Month (only) **] between 32 and 35 weeks with two of three of the following: daycare during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities, or with preschool siblings, or 3) with chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age, the family and other caregivers should be considered for immunization against influenza to protect the infant.
Status post prematurity 35 weeks gestation.
Status post intrauterine growth restriction.
